{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:45:05Z","timestamp":1768405505297,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016308","name":"OSEO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005897","name":"SFD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009406","name":"CHU Nantes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.diabet.2025.101621","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:56:05Z","timestamp":1738601765000},"page":"101621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lp(a) concentration and polymorphic size are not associated with new onset diabetes in individuals with prediabetes"],"prefix":"10.1016","volume":"51","author":[{"given":"Maxime","family":"Carpentier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Wargny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Le May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Smati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Bigot-Corbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1580-8040","authenticated-orcid":false,"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2025.101621_bib0001","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabet.2025.101621_bib0002","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(24)01308-4","article-title":"Lipoprotein(a) and cardiovascular disease","volume":"404","author":"Nordestgaard","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2025.101621_bib0003","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1373\/clinchem.2010.146779","article-title":"Lipoprotein(a) and risk of type 2 diabetes","volume":"56","author":"Mora","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabet.2025.101621_bib0004","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.acvd.2021.10.009","article-title":"Lipoprotein(a): pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Soci\u00e9t\u00e9 Francophone d'Ath\u00e9roscl\u00e9rose (NSFA)","volume":"114","author":"Durlach","year":"2021","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2025.101621_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221524","article-title":"Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: the IT-DIAB study","volume":"14","author":"Wargny","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2025.101621_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101391","article-title":"Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: a prospective cohort study","volume":"49","author":"Pires Da Silva","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2025.101621_bib0007","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1194\/jlr.D120000835","article-title":"A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins","volume":"61","author":"Blanchard","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2025.101621_bib0008","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/ATVBAHA.115.305835","article-title":"Effects of extended-release nicotinic acid on apolipoprotein (a) kinetics in hypertriglyceridemic patients","volume":"35","author":"Croyal","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.diabet.2025.101621_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/bimj.201700067","article-title":"Variable selection - A review and recommendations for the practicing statistician","volume":"60","author":"Heinze","year":"2018","journal-title":"Biom J"},{"key":"10.1016\/j.diabet.2025.101621_bib0010","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1194\/jlr.P049015","article-title":"Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population","volume":"56","author":"Ding","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2025.101621_bib0011","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1373\/clinchem.2017.277103","article-title":"Kringle IV type 2, not low lipoprotein(a), as a cause of diabetes: a novel genetic approach using SNPs associated selectively with lipoprotein(a) concentrations or with Kringle IV type 2 repeats","volume":"63","author":"Tolbus","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.diabet.2025.101621_bib0012","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1194\/jlr.P082792","article-title":"LPA Kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk","volume":"59","author":"Mu-Han-Ha-Li","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.diabet.2025.101621_bib0013","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2019.10.019","article-title":"Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes","volume":"74","author":"Gudbjartsson","year":"2019","journal-title":"J Am College Cardiol"},{"key":"10.1016\/j.diabet.2025.101621_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-022-01452-5","article-title":"Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes","volume":"21","author":"Croyal","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2025.101621_bib0015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2337\/dc20-2842","article-title":"Relation of Lipoprotein(a) levels to incident type 2 diabetes and modification by alirocumab treatment","volume":"44","author":"Schwartz","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363625000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T04:41:34Z","timestamp":1740717694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363625000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1262363625000163"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101621","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lp(a) concentration and polymorphic size are not associated with new onset diabetes in individuals with prediabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2025.101621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101621"}}